MicroRNA-21 is a novel promising target in cancer radiation therapy

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) are noncoding RNA molecules crucial in gene regulation.
• MicroRNA-21 (miR-21) is frequently dysregulated in various cancers, impacting tumor progression.
• miR-21's role in carcinogenesis, recurrence, and metastasis makes it a potential therapeutic target.

Purpose of the Study:

• To review the function of miR-21 in cancer radiation therapy.
• To explore the molecular mechanisms of miR-21 in radiosensitivity and radioresistance.
• To discuss current and future applications of miR-21 in cancer treatment.

Main Methods:

• Literature review of studies on miR-21 and cancer radiation therapy.
• Analysis of miR-21's influence on cellular processes during irradiation.
• Examination of molecular pathways affected by miR-21.

Main Results:

• miR-21 influences critical cancer cell processes including cell cycle, DNA repair, apoptosis, autophagy, and hypoxia during irradiation.
• Dysregulation of miR-21 is linked to radiosensitivity and radioresistance.
• miR-21 presents potential as a biomarker and therapeutic target in radiation oncology.

Conclusions:

• miR-21 is a significant factor in cancer response to radiation therapy.
• Understanding miR-21's mechanisms can lead to improved cancer treatment strategies.
• Targeting miR-21 offers promising avenues for enhancing radiation therapy efficacy.